ViGenCell

ViGenCell EPS

The Earnings per Share (EPS) of ViGenCell (308080.KQ) as of Oct 20, 2026 is -796.24 KRW. In the previous year, Earnings per Share (EPS) was -729.64 KRW — a change of 9.13% (lower).

EPS

-796.24KRW

YoY

9.13%

Last updated:

Earnings per Share (EPS) of ViGenCell is 2025 -796.24 KRW. Earnings per Share (EPS) of ViGenCell was 2024 -729.64 KRW. It decreases by 9.13% lower compared to the previous year.

The ViGenCell EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-1,188.98 KRW
Jan 1, 2020
-554.19 KRW
Jan 1, 2021
-588.52 KRW
Jan 1, 2022
-915.14 KRW
Jan 1, 2023
-932.68 KRW
Jan 1, 2024
-729.64 KRW
Jan 1, 2025
-796.24 KRW
The ViGenCell EPS history
YEAREPSYoY
-796.24KRW+9.13%
-729.64KRW-21.77%
-932.68KRW+1.92%
-915.14KRW+55.50%
-588.52KRW+6.19%
-554.19KRW-53.39%
-1,188.98KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ViGenCell Stock analysis

What does ViGenCell do? ViGenCell Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company has 80 employees and completed its initial public offering (IPO) on August 25, 2021. ViGenCell focuses on research and development in natural science and engineering, with a particular emphasis on cell therapy technologies. The company develops and manufactures immuno-cancer cell therapy products and immunosuppressive cell therapy products. It also provides the Vitier platform, which is an antigen-specific killing T cell treatment, the Viranger platform for gamma delta T cell gene therapy, and the Vimedier platform-based technology for myeloid suppressor cell therapy derived from umbilical cord blood. ViGenCell is engaged in the research and development of new drugs targeting conditions such as acute myeloid leukemia (AML) and glioblastoma. The company's website is https://www.vigencell.com/. ViGenCell Inc is listed on the Korean stock market under the ticker 308080.KQ and has the ISIN KR7308080001. The company's headquarters are located in Seoul, South Korea. ViGenCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViGenCell stock

Earnings per Share (EPS) of ViGenCell is -796.24 KRW in 2025.

Earnings per Share (EPS) of ViGenCell changed from -729.64 KRW to -796.24 KRW, representing a 9.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) ViGenCell since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ViGenCell

All Key Metrics — ViGenCell